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Abstract
DNA methylation is one of the most studied and important epigenetic modifications
in cells, playing a role in DNA transcription, splicing, and imprinting. Recently, ad-
vanced genome-wide DNA methylation profiling technologies have been developed,
making it possible to conduct methylome-wide association studies. One of the prob-
lems with large scale DNA methylation studies is that the current technologies are
either targeting only a limited number of CpG sites in the genome or whole genome
sequencing is expensive and time consuming for most laboratories. Computational
prediction of CpG site-specific methylation levels is the cost-saving and time-saving
alternative.
In this work, we found striking patterns of DNA methylation across the genome.
We show that correlation among CpG sites decays rapidly within several hundreds
base pairs in contrast to the LD structure of genotypes which holds for up to several
KB. Using genomic features including, neighbor CpG site methylation and genomic
distance, genomic context such as CpG island regions, and genomic regulatory ele-
ments, we built random forest classifiers to predict CpG site methylation levels. Our
approach achieves 92% prediction accuracy at single CpG sites in different genome-
wide methylation datasets. We achieves the highest accuracy as 98% for prediction
within CpG island regions. What’s more, our method identifies genomic features that
interact with DNA methylation, which improves our understanding of mechanisms
involved in DNA methylation modification and regulation.
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1Introduction
Epigenetics is the study of changes in gene expression or complex phenotype that
are not associated with changes in DNA sequence. Epigenetics has been shown to
be a critical process in cell differentiation, development, and tumorigenesis (Kiefer,
2007; Tost, 2010). DNA methylation is probably the most studied epigenetic mod-
ification of DNA, but our understanding of DNA methylation is still in its infancy.
In vertebrates, DNA methylation occurs by adding a methyl group to the fifth car-
bon of the cytosine residue, mainly in the context of 5-CG-3 dinucleotides, or CpG
sites, mediated by DNA methyl-transferases (DNMTs) (Cedar, 1988; Jaenisch and
Bird, 2003). DNA methylation has been shown to play an important functional role
in the cell, including involvement in DNA replication and gene transcription, thus
playing a crucial role development, aging, and cancer (Barrero et al., 2010; Wolffe,
1999; Rivenbark et al., 2012; Das and Singal, 2004; Scarano et al., 2005; Cedar and
Bergman, 2012).
CpG site are underpresented relative to their expected frequency as a result of be-
ing a mutation hotspot, where the deamination of methylated cytosines often changes
CpG sites into TpG sites (Tost, 2010; Lienert et al., 2011). Although CpG site are
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mainly methylated across the mammalian genome (Jones, 2012), there are distinct,
mostly unmethylated CG-rich regions termed CpG islands (CGIs) that have a G+C
content greater than 50% (Tost, 2010; Lienert et al., 2011; Law and Jacobsen, 2010).
CGIs account for 1 ´ 2% of the genome, and are often located in promoters and
exonic regions in mammalian genomes (Shen et al., 2007; Larsen et al., 1992). These
CGIs are shown to co-localize with DNA regulatory elements such as transcription
factor binding sites (TFBSs) (Brandeis et al., 1994; Macleod et al., 1994; Dickson
et al., 2010; Teschendorff et al., 2009; Deaton and Bird, 2011; Choy et al., 2010;
Gebhard et al., 2010; Stirzaker et al., 2004) and DNA binding insulator proteins,
such as CTCF, which protect downstream DNA from upstream methylation activi-
ties (Valenzuela and Kamakaka, 2006). Furthermore, DNA methylation levels have
been shown to correlate with gene regions, active chromatin marks (Weber et al.,
2007; Meissner et al., 2008; Hawkins et al., 2010), cis-acting DNA regulatory ele-
ments, and proximal sequence elements (Shen et al., 2007; Das et al., 2006).
The non-uniform distribution of CpG sites across the human genome and the
important role of methylation in cellular processes indicate that genome-wide DNA
methylation patterns are needed to fully explore the regulatory mechanism of this
critical process (Laird, 2010). Recent advances in methylation-specific microarray
and sequencing technologies have enabled the assay of DNA methylation patterns
genome-wide and at single base-pair resolution. The current gold standard to asses
single-base-pair DNA methylation patterns across the genome within an individual
is whole genome bisulfite sequencing (WGBS), which quantifies DNA methylation
levels at „ 26 million (out of 28 million total) CpG sites in the human genome (Lau-
rent et al., 2010; Hon et al., 2011; Lister et al., 2009). However, WGBS is expensive
and time-consuming for large samples and can be subject to bisulfite conversion bias.
As an alternative, methylation-specific microarrays, and the Illumina HumanMethy-
lation 450K Beadchip in particular, measure bisulphite treated DNA methylation
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levels at approximatedly 485, 000 preselected CpG sites (Bibikova et al., 2011); how-
ever, these arrays assay less than 2% of CpG sites, and this percentage is biased
to gene regions. Therefore, quantitative methods are needed to predict methylation
status at unassayed sites and genomic regions.
Genome-wide methylation analyses have enabled the study of global methylation
patterns of the human genome at single CpG site resolution. In this study, we
examined measurements of methylation levels in 100 individuals using the Illumina
450K Beadchip, and one individual using whole genome bisulfite sequencing. Within
these methylation profiles, we examined the methylation patterns and correlation
structure of these CpG sites, with attention to characterizing methylation patterns
in CGI regions. Using features that include neighboring CpG site methylation status
and other genomic attributes, we developed a random forest classifier to predict
single CpG site methylation status. Using our classifier, we are able to identify DNA
regulatory elements that may affect DNA methylation (or vice versa), providing
hypotheses for experimental studies on mechanisms by which methylation leads to
biological changes or disease phenotypes.
3
1.1 Related work in DNA methylation prediction
A number of methods to predict methylation status have been developed; see Ap-
pendix A for a complete list. Across these methods, a common simplifying as-
sumption is that methylation status is a binary variable, e.g., a CpG site is either
methylated or unmethylated in an individual (Bhasin et al., 2005; Bock et al., 2006;
Das et al., 2006; Fang et al., 2006; Kim et al., 2008; Fan et al., 2008; Lu, 2010; Zheng
et al., 2013). These methods have often limited their predictions to specific regions
of the genome, such as CpG Islands (Bock et al., 2006; Kim et al., 2008; Fang et al.,
2006; Fan et al., 2008; Previti et al., 2009; Zheng et al., 2013). More broadly, all
of these methods make predictons of average methylation status for windows of the
genome instead of individual CpG sites.
The majority of these methods are based on a support vector machine (SVM)
classifier (Bhasin et al., 2005; Bock et al., 2006; Das et al., 2006; Fang et al., 2006; Fan
et al., 2008; Previti et al., 2009; Zhou et al., 2012; Zheng et al., 2013). In Previti et
al., their decision tree classifier achieved better performance than an SVM-based
classifier. Similarly, Kim et al. achieved the best prediction performance using a
naive Bayes classifier, and Lu et al. used word composition-based encoding method.
Across these methods, features that are used for DNA methylation prediction
include, with respect to the genomic region for which methylation is being pre-
dicted, DNA composition (proximal DNA sequence patterns), predicted DNA struc-
ture (e.g., co-localized introns), repeat elements, TFBSs, evolutionary conservation
(e.g., PhastCons (Siepel et al., 2005)), number of SNPs, GC content, Alu elements,
histone modification marks, and functions of nearby genes. Several studies only used
DNA composition features for prediction and achieved prediction accuracies rang-
ing from 75% to 87% (Bhasin et al., 2005; Das et al., 2006; Kim et al., 2008; Lu,
2010; Zhou et al., 2012). In addition to DNA composition features, Fan et al. added
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histone modification marks. Bock et al. used „ 700 features including DNA com-
position, DNA structure, repeat elements, TFBSs, evolutionary conservation, and
number of SNPs; Zheng et al. included „ 300 features including DNA composition,
DNA structure, TFBSs, histone modification marks, and function of nearby genes.
They achieved prediction accuracy around 90%. Two other studies did not use any
DNA composition features: Fang et al. used GC content, Alu elements, and TFBSs,
while Previti et al. used GC content, repetitive sequences, evolutionary conservation,
and DNA structure; their accuracy ranged from 85% to 92%.
The relative success of each of these methods depends on the prediction objec-
tives. Many of the studies, including all the studies that achieved high prediction
accuracy (ě 90%) (Bock et al., 2006; Fan et al., 2008; Previti et al., 2009; Zheng
et al., 2013), only predicted average methylation status within CGIs or DNA frag-
ments within CGIs. Most of the CpG sites in CGIs are unmethylated across the
genome (Jones, 2012; Maunakea et al., 2010) – Manuakea et al. found that 16%
of all CGIs in cells from human brain were methylated using a WGBS approach –
so it is not particularly surprising that classifiers limited to these regions perform
well. Studies not limiting prediction to CGI uniformly achieved lower accuracies,
ranging from 75% to 86%. Only one of these studies predicted methylation as a con-
tinuous variable (Zhou et al., 2012). Their methylation level predictions achieved a
maximum correlation coefficient of 0.82 and a corresponding root mean square error
of 0.20; however, the study was limited to about 400 DNA fragments instead of a
genome-wide analysis.
Our DNA methylation classifier differs from the above methods in that it:
• uses a genome-wide approach,
• is at single CpG site resolution,
• predicts DNA methylation levels instead of status;
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• is based on a random forest classifier,
• incorporates a diverse set of genomic features, and
• considers the mechanistic interpretation of the features.
We find that these differences substantially improve the performance of the classifier,
and also provide biological insights into how methylation regulates, or is regulated
by, specific genomic processes.
6
2Materials and methods
2.1 DNA methylation data
2.1.1 Methylation450K data
Illumina HumanMethylation450K array data were obtained for 100 unrelated human
participants from the TwinsUK cohort (Moayyeri et al., 2012) All participants pro-
vided written informed consent in accordance with local ethics research committees.
The 100 individuals were adult unselected volunteers and included 97 female and
3 male individuals (age range 27–78). Whole blood was collected and DNA was
extracted using standard protocols.
Illumina HumanMethylation450K array (Illumina 450K) measured DNA methy-
lation values for more than 482, 000 CpG sites per individual at single-nucleotide
resolution. Genomic coverage includes 99% of reference sequence genes, with an
average of 17 CpG sites per gene region distributed across the promoter, 5’UTR,
first exon, gene body, and 3’UTR, and 96% of CpG islands (Rechache et al., 2012;
Bibikova et al., 2011).
Methylation values for each CpG site are quantified by the term β, which is the
fraction of methylated bead signal over the sum of methylated and unmethylated
7
bead signal:
β “ maxpMethy, 0q
maxpMethy, 0q `maxpUnmethy, 0q ` α (2.1)
where Methy represents the signal intensity of the methylated probe and Unmethy
represents the signal intensity of the unmethylated probe. The quantity β ranges
from 0 (unmethylated) to 1 (fully methylated).
Data quality control was implemented using R (http://www.r-project.org/) (ver-
sion 2.15.3). We removed 17, 764 CpG sites for which probes mapped to multiple
loci in the human genome reference sequence. CpG sites that are SNPs, that had
missing values, or that had detection p-values ą 0.01 were excluded. Methylation
data from probes mapping to the X and Y chromosomes were excluded. We were
left with 394, 354 CpG sites from 100 individuals in downstream analyses. The data
were controlled for array number, sample position on the array, age, and sex by fitted
linear regression model. The sum of residuals and intercepts of each sites were scaled
to the original r0, 1s scale by truncating all sites with values larger than 1 to 1 and
all sites with values smaller than 0 to 0. Data quality was assessed to identify sample
outliers and batch effectss using Principal Component Analysis (PCA) Gabriel and
Odoroff (1990), no obvious outlier was identified.
2.1.2 Whole Genome Bisulfite Sequencing data
We downloaded the WGBS data (BED files) from NCBI Gene Expression Omnibus
(GEO) ID GSE46644, sample GSM791827 (Ziller et al., 2013; Hodges et al., 2011).
CD19+ B cells were purified from peripheral blood collected from one healthy female
donor. Bisulfite sequencing and read mapping processes were described in previous
work (Hodges et al., 2011). The methylation levels for each CpG site were quantified
by the ratio of the number of methylated and the total reads at each CpG site. Only
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CpG sites with greater than 5X coverage were included. Methylation level data
from the X and Y chromosomes were excluded. After quality control, there were
10, 000, 890 CpG sites in the WGBS data. Because we only used a single sample, we
did not control for principal components.
2.2 Correlation and PCA
The statistical analyses were implemented using R and Bioconductor
(http://www.bioconductor.org/) (version 2.15.3). Methylation correlations between
CpG sites were assessed by the absolute value of Pearson’s correlation coefficient and
mean square error (MSE):
MSE “
řn
i“1px1i ´ x2iq2
n
, (2.2)
where x1i and x2i represent the methylation values of the two CpG sites being com-
pared, n represents the total number of CpG sites being compared.
We performed PCA on methylation values of CpG sites by computing the eigen-
values of the covariance matrix of a subsample of CpG sites using the R function svd.
Among the 378, 677 CpG sites that have complete feature information, 37, 868 sites
(every tenth CpG site) were sampled along the genome across all autosomal chromo-
somes. Absolute value Pearson’s correlation was calculated between each feature and
first ten PCs. PCA analysis was performed by plotting the PC biplot (scatterplot of
first two PCs).
2.3 Random forest and comparison classifier
The random forest classifier is a widely-used classification method that combines the
idea of bagging classification trees and randomizing feature subsets (Breiman, 2001).
Compared with traditional decision trees, a random forest randomly generates a set
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of independent predictors to extend each tree. To determine the most discriminative
feature to add to a tree, the random forest algorithm uses a type of bagging, where a
bootstrap sample (a random sample without replacement) is selected from training
data to grow each tree, while the remaining training data are used to determine
the split that yields the best generalization error (where each split is determined
using only a random subset of the features). After each tree has been estimated,
they perform prediction by voting on the prediction value, and the final prediction
is chosen by majority vote but can be interpreted as the proportion of trees with a
‘1’ prediction (Breiman, 1996, 2001).
Random forest classifiers have been shown to produce low-bias trees and have
low correlation among individual trees, creating efficient classifiers, particularly on
high-dimensional, noisy data. Moreover, both categorical and continuous prediction
features are allowed, and the tree structure explicitly captures interactions among
features (Dı´az-Uriarte and Alvarez de Andre´s, 2006). Due to the random selection
of predictors at each tree, the performance of the random forest classifier is highly
accurate even when many of the features are not predictive, as long as there are
sufficient numbers of trees, avoiding the need for rigorous feature selection (Hua et al.,
2005). The random forest classifier also enables feature importance to be quantified,
allowing us to functionally interpret the relationship between DNA methylation and
specific genomic features.
We used the randomForest package in R for the implementation of the RF clas-
sifier (Liaw and Wiener, 2002) (version 4.6-7). Most of the parameters were kept
as default, but ntree was set to 1, 000 to balance efficiency and accuracy in our
high-dimensional data. We found the parameter settings for the random forest clas-
sifier (including the number of trees) to be robust to different settings, so we did
not estimate parameters in our classifier. The Gini index, which calculates the total
decrease of node impurity (i.e., the relative entropy of the class proportions before
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and after the split) of a feature over all trees, was used to quantify the importance
of each feature:
IpAq “ 1´
cÿ
k“1
p2k, (2.3)
where k represents the class and pk is the proportion of sites belonging to class k in
node A.
We used the SVM implementation in the e1071 package in R (Meyer et al., 2012)
with a radial basis function kernel. The parameters of the SVM were optimized using
grid search. The penalty constant C ranged from 2´1, 21, ..., 29 and the parameter γ
in the kernel function ranged from 2´9, 2´7, ..., 21. The parameter combination that
had the best performance – γ “ 2´7 and C “ 23 – was used to generate the results
used in the comparisons.
For k-NN, we used the knn function in R, with the number of neighbors equal to
the square root of number of samples in the training set.
For the LR classifier, we used the logistic regression classifier implemented in
the R base package with the function glm and family = ‘binomial’. We set the
threshold for classification to βˆi,j ě 0.5.
For the NB classifier, we used the naiveBayes function in the R e1071 package.
2.4 Features for prediction
A comprehensive list of 124 features were used in prediction (Table S2). The neigh-
bors features were obtained from data from the Methylation 450K Array; The po-
sition features, including gene coding region category, location in CGIs, and SNPs,
were obtained from the Methylation 450K Array Annotation file; DNA recombi-
nation rate data was downloaded from HapMap (phaseII B37, update date Jan19-
2011) (Tanaka, 2005); GC content data were downloaded from the raw data used to
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encode the gc5Base track on hg19 (update date Apr242009) from the UCSC Genome
Browser (http://hgdownload.cse.ucsc.edu/goldenPath/hg19/gc5Base/) (Meyer et al.,
2013), integrated haplotype scores (iHS scores) were downloaded from the HGDP
selection browser iHS data of smoothedAmericas (update date Feb122009) (Voight
et al., 2006), and GERP constraint scores were downloaded from SidowLab GERP++
tracks on hg19 (http://mendel.stanford.edu/SidowLab/downloads/gerp/) (Davydov
et al., 2010); CREs features: DNAse I hypersensitive sites data were obtained from
the DNase-seq data for the GM12878 cell line produced by Crawford Lab at Duke
University (UCSC Accession: wgEncodeEH000534, submitted date Mar202009); 79
specific transcription factor binding sites ChIP-seq data were obtained from the nar-
row peak files from GM12878 cell line that were available before June 2012 from
the ENCODE website; 10 histone modifications were obtained from the peak files
from the GM12878 cell line that were available before December 2013 from the EN-
CODE website; 15 chromatin states were obtained from the Broad ChromHMM data
from the GM12878 cell line (UCSC Accession: wgEncodeEH000033 submitted data
Mar212011) (Good et al., 2004).
Neighboring CpG site methylation status was encoded as ”methylated” when the
site has a β ą 0.5% and ”unmethylated” when β ă 0.5%. For continuous features,
the feature value is the value of that feature at the genomic location of the CpG
site; for binary features, the feature status indicates whether the CpG site is within
that genomic feature or not. DHS sites were encoded as binary variables indicating a
CpG site within a DHS site; TFBSs were included as binary variables indicating the
presence of a co-localized ChIP-Seq peak; iHS scores, GERP constraint scores and
recombination rates were measured in terms of genomic regions; For GC content,
we computed the proportion of G and C within a sequence window of 400 bp, as
this feature was shown to be an important predictor in previous study (Fang et al.,
2006). Among all 124 features, 122 of them (excluding upstream and downstream
12
neighboring CpG sites’ β values) were used for methylation status predictions, and
all excluding upstream and downstream neighboring CpG sites’ methylation status
τ were used for methylation level predictions. When limiting prediction to specific
regions, e.g., CGI, we excluded those features from the data.
2.5 Prediction evaluation
Our methylation predictions were at single CpG site resolution. For regional specific
methylation prediction, we grouped the CpG sites into either promoter, gene body,
intergenic region classes or CGI, CGI shore & shelf, and non-CGI classes according to
the Methylation 450K array annotation file, which was downloaded from the UCSC
genome browser (Kent et al., 2002). We only counted CpG sites that have both
upstream and downstream neighboring sites in same region. Since the array has
non-uniformly distributed probes, the density of probe is highly skewed to promoter
and CGI region. To reduce the influence of probe density on the performance of
regional specific prediction, we only predicted on CpG sites with neighboring sites
within 1kb distance. The feature of gene coding region category and CGI status
were excluded in different gene coding region prediction and different CGI status
prediction, respectively.
The classifier performance was assessed by within-genome, cross-sample and
cross-platform validation. In within-genome analyses, ten times we sampled 10, 000
random CpG sites from across the genome into the training set, and we tested on
all other held-out sites. The prediction performance for a single classifier was calcu-
lated by averaging the prediction performance statistics across each of the 10 trained
classifiers. We checked the performance with smaller training set of sizes 100, 1000,
2000, 5000 and 10, 000 sites in the same evaluation setup. In subsequent analyses,
we set the size of the training set to 10, 000 randomly chosen CpG sites to balance
computational performance and accuracy. For genomic region specific methylation
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prediction, the number of sites in each catagory are shown in Tabel 4. The validation
was repeated n times where n represents the number of 10, 000 sites training sets in
corresponding region. Next, we expand our analyses to the whole genome of each
of 100 individual. We considered cross-sample validation to evaluate the consistency
of methylation pattern in different individuals. In this case, training was performed
from 10, 000 CpG sites in one sample, and the trained classifier was used to predict
all of the methylated sites in the remaining 99 samples.
In cross-platform prediction and WGBS prediction, we sampled 10, 000 randomly
chosen CpG sites from 450K data or CpG sites categorized as 450K sites in WGBS
data as training sets. We tested on 100, 000 randomly chosen CpG sites that were
categorized as 450K site or non 450K site in the WGBS data. The prediction perfor-
mance for a single classifier was calculated by averaging the prediction performance
statistics across each of the 10 trained classifiers.
We quantified the accuracy of the results using the specificity, sensitivity (recall),
precision, and accuracy (ACC). Note that truly significant CpG sites are those that
are methlyated, and truly null CpG sites are those that are unmethylated in these
data. These values were calculated as follows:
SP “ TN
TN ` FP (2.4)
SE “ TP
TP ` FN (2.5)
Precision “ TP
TP ` FP (2.6)
Recall “ TP
TP ` FN (2.7)
ACC “ TP ` TN
TP ` FP ` TN ` FN (2.8)
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for true positives (TP), true negatives (TN), false positives (FP), and false nega-
tives (FN) for a particular threshold. We computed Receiver Operating Character-
istic (ROC) curves, precision-recall curves, area under the ROC curve (AUC), and
area under precision-ecall curve (AUPR); the AUC and AUPR reflect the overall pre-
diction performance considering both type I (FPs) and type II errors (FNs) (Bhasin
et al., 2005; Fogarty et al., 2005). We used the ROCR package in R (Sing et al., 2005).
To estimate continuous methylation levels ( ˆbeta), we used the classifier output
of prediction probability from the RF classifier directly as an estimate of a specific
β P r0, 1s. Prediction accuracy was evaluated using Pearson’s correlation coefficient
and root mean squared error (RMSE).
rx,y “
řp
j“1pxj ´ x¯qpyj ´ y¯q
pp´ 1q ¨ σx ¨ σy (2.9)
RMSEx,y “
dřp
j“1pyj ´ xjq2
p
(2.10)
where xj, yj are the experimental and predicted values for the j
th CpG site, respec-
tively, x¯, y¯ are the means of the experimental and predicted methylation levels,
respectively, and σx, σy are the empirical standard deviations of the experimental
and predicted values, respectively.
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3Results
3.1 Characterizing methylation patterns
First we examined the distribution of DNA methylation values, β, at CpG sites
on autosomal chromosomes across all 100 individuals (Figure 3.1A). The majority
of CpG sites were either hypermethylated or hypomethylated, with 48.2% of sites
having β ą 0.7% and 40.4% of sites having β ă 0.3. Using a cutoff of β “ 0.5, across
the methylation profiles and individuals, 54.8% of these CpG sites are methylated.
We observed distinct patterns of DNA methylation levels in different genomic regions
(Figure 3.1B). In the following analysis, we identified co-located CGIs using UCSC
genome browser (Kent et al., 2002); CGI shores are regions 0 ´ 2 kb away from
CGIs in both directions and CGI shelves are regions 2 ´ 4 kb away from CGIs in
both directions (Bibikova et al., 2011). We found that CpG sites in CGIs were
mostly hypomethylated and sites in non-CGIs were mostly hypermethylated, while
CpG sites in CGI shore regions had variable methylation levels following a U-shape
distribution, and CpG sites in CGI shelf regions were highly hypermethylated. These
distinct patterns reflect highly context-specific DNA methylation profiles genome-
16
wide, leading us to perform a more careful analysis of DNA methylation levels at
these loci.
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Figure 3.1: Distribution of DNA methylation levels at CpG sites across autosomal
chromosomes.
Methylation levels across 100 individuals at CpG sites assayed on the 450K array.
Panel A: Distribution of DNA methylation values across all CpG sites. Panel B:
Distribution of DNA methylation values for CpG sites within CGIs, CGI shores,
CGI shelves, and non-CGI regions.
DNA methylation levels at nearby CpG sites have previously been found to be
correlated within short genomic regions of 1´2 kb (Bell et al., 2011; Eckhardt et al.,
2006), in contrast with the correlation among genotypes due to linkage disequilibrium
(LD) that often extends to large genomic regions from a few kilobases to as much
as 100 kb (Reich et al., 2001). We quantified the correlation of methylation levels
between neighboring CpG sites in our data using the absolute value of Pearson’s
correlation. We found that correlation of methylation status between neighboring
CpG sites decreased rapidly to approximately 0.4 within about 400 bp, in contrast
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to 1´ 2 kb in previous studies (Bell et al., 2011; Eckhardt et al., 2006) with sparser
CpG coverage (Figure 3.2A). We found the rate of decay in correlation to be highly
dependent on genomic context; for example, for neighboring CpG sites in the same
CGI shore and shelf region, correlation decreases continuously until it is well below
what is expected (Figure 3.2A). Because of the over-representation of CpG sites
near CGIs on the array, an increase in correlation can be observed as neighboring
sites extend past the CGI shelf regions, where there is lower correlation with CGI
methylation levels than we observe in the background.
Figure 3.2: Correlation of methylation levels between neighboring CpG sites.
The x-axis represents the genomic distance in bases between the neighboring CpG
sites, or assayed CpG sites that are adjacent in the genome. Different colors and
points represent subsets of the CpG sites genome-wide, including pairs of CpG sites
that are not adjacent in the genome but that are the specified distance apart (non-
adjacent). The CGI shore & shelf CpG sites are truncated at 4000 bp, which is the
length of the CGI shore & shelf regions. The solid horizontal line represents the
background (absolute value correlation or MSE) levels averaged from 10, 000 pairs of
CpG sites from arbitrary chromosomes. Panel A: the absolute value of the correlation
between neighboring sites across all individuals (y-axis). The lines represent cubic
smoothing splines fitted to the correlation data. Panel B: the MSE was calculated for
CpG sites (y-axis) for each pair of CpG sites within the genomic distance window.
We contrast this decay to the background correlation level, (0.259), which is the
18
average absolute value correlation between pairs of randomly selected CpG sites
across chromosomes (Figure 3.2A, Figure 3.3). We found substantial differences in
correlation between neighboring CpG sites versus arbitrary pairs of CpG sites at
identical distances, presumably because of the dense CpG tiling on the 450K array
within CGI regions. While correlation decays rapidly within approximately 400 bp
between neighboring sites, neighbor correlation does not achieve background corre-
lation levels until several MB, suggesting DNA methylation patterns that expand to
large genomic regions.
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Figure 3.3: Correlation and MSE of methylation values between arbitrary pairs of
CpG sites.
The x-axes represent the genomic distance between pairs of CpG sites; The left
column shows the correlation of CpG sites within 100 kb (Panel A), 1 Mb (Panel C)
and 10 Mb (Panel E); the right column plots show the MSE patterns of CpG sites
in relation to their genomic distances with distance range 100 kb (Panel B), 1 Mb
(Panel D) and 10 Mb (Panel F). The solid horizontal lines represent the background
correlation or MSE level calculated from 10000 pairs of CpG sites from a different
chromosome.
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To quantify the correlation patterns in DNA methylation profiles of neighboring
CpG sites within individuals, we calculated the mean square error (MSE) for DNA
methylation levels between neighboring CpG sites ( Figure 3.2B, Figure 3.3). In
general, the MSE trends echo the local patterns seen in the correlation analysis and
also appear to be region specific. In CGI regions, the MSE of neighboring sites was
low and increased slowly with genomic distance. In contrast, MSE in CGI shore
and shelf regions increased rapidly to an MSE higher than background MSE (0.30),
indicating that the edges of a single shore and shelf region are less predictive of each
other than any two CpG sites at random.
As we observed that methylation patterns at neighboring CpG sites depended
heavily on genomic content, we further investigated methylation patterns within
CGIs, CGI shores, and CGI shelves. Methylation levels at CGIs and CGI shelves were
fairly constant genome-wide and across individuals with CGIs being hypomethylated
and CGI shelves being hypermethylated. (Figure 3.4A). In contrast, CpG sites in
CGI shores have a monotone increasing pattern of methylation status from CGIs
towards CGI shelves, and this pattern is symmetric in the CGI shores upstream
and downstream of CGIs. This explains the high levels of variation we observed in
methylation values of CpG sites in CGI shore regions If we examine the MSE between
pairs of CpG sites’ methylation status in these regions, we find that MSE within the
CGI and within the CGI shelves is low, consistent with the variance we observed
within DNA methylation profiles in these regions (Figure 3.4B). Additionally, we
find that the MSE between the CpG sites in the shelves appears to increase as the
sites are further away from the CGI on the shelf, suggesting a circular dependency
in methylation status between the ends of the shelf sequences.
To quantify the amount of variation in DNA methylation explained by genomic
context, we considered the correlation between genomic context and principle com-
ponents (PCs) of methylation levels across all 100 individuals (Figure 3.5). We found
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Figure 3.4: Methylation structure with respect to CpG islands status.
Since each CGI is a different length, each CGI was split into 40 equal sized windows.
Panel A: The points represents the mean β in CGIs, CGI shores or CGI shelves
across all sites in all individuals with a window size of 100 bp. Panel B: Methylation
levels of each CpG site in each CGI, CGI shore, and CGI shelf were compared with
all the other sites in the same CGI region. X-axis and y-axis represent the genomic
position of each CGI with a scale of 1:100, i.e. one unit in matrix represents 100 bp
distance. The MSE of each unit cell was calculated for all pairwise CpG sites with
one site located in the relative scaled position on x-axis and the other one on y-axis,
and then averaged over 100 individuals.
that many of the features derived from the CpG site’s genomic context appear to
be correlated with the first principal component (PC1). Methylation statuses of
upstream and downstream neighboring CpG sites and a co-localized DNAse I hy-
persensitive (DHS) site are the most highly correlated features, both with Pearson’s
correlation around 0.57 (Figures 3.5). Ten genomic features all have correlation ą 0.5
with PC1, including co-localized active TFBSs Elf1 (ETS-related transcription fac-
tor 1), MAZ (Myc-associated zinc finger protein), Mxi1 (MAX-interacting protein 1)
and Runx3 (Runt-related transcription factor 3), suggesting that they may be useful
in predicting DNA methylation status.
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Figure 3.5: Correlation matrix of prediction features with first ten principle com-
ponents of methylation levels.
PCA is performed on methylation levels for 37, 865 CpG sites. The correlation with
each of the features was calculated between the first ten methylation PCs (y-axis)
and all features (x-axis).
3.2 DNA methylation prediction
3.2.1 Binary methylation status prediction
These observations about patterns of DNA methylation suggest that correlation in
DNA methylation is local and dependent on genomic context. Thus, prediction of
DNA methylation status based only on methylation levels at neighboring CpG sites
may not perform well, especially in sparsely assayed regions of the genome. Using
prediction features including neighboring CpG site methylation levels and features
characterizing genomic context, we built a classifier to predict DNA methylation
status, assuming binary status indicating no methylation (0) or complete methylation
(1). For each sample, there were 378, 677 CpG sites with neighboring CpG sites on
the same chromosome that we used in these analyses.
The 124 features that we used for DNA methylation status prediction fall into
four different classes (see Appendix B). For each CpG site, we include:
• neighbors : one upstream and one downstream neighboring (CpG sites assayed
on the array and adjacent in the genome) CpG sites’ genomic distances, binary
methylation status and levels β,
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• genomic position: binary values indicating co-localization of CpG site with
DNA sequence annotations, including promoters, gene body, intergenic region,
CGIs, CGI shores and shelves, and nearby SNPs;
• DNA sequence properties : continuous values representing the local recombi-
nation rate from HapMap (Tanaka, 2005), GC content from ENCODE (Good
et al., 2004), integrated haplotype scores (iHS) (Voight et al., 2006), and ge-
nomic evolutionary rate profiling (GERP) calls (Davydov et al., 2010).
• CREs : binary values indicating CpG site co-localization with cis-regulatory
elements (CREs), including DHS sites, 79 specific TFBSs, 10 histone modifica-
tion marks and 15 chromatin states, all assayed in the GM12878 cell line, the
closest match to whole blood (Good et al., 2004)
We built our classifier using a random forest (RF), which is an ensemble classifier
that uses a collection of decision trees. We used a cutoff of 0.5 for prediction output,
i.e, The prediction with a probability above 0.5 is categrized as methylated site. We
quantified prediction accuracy, specificity, sensitivity (recall), precision (1 - false dis-
cover rate), area under the Receiver Operating Characteristic (ROC) curve (AUC),
and area under the precision recall curve (AUPR) to evaluate our predictions.
Using 122 features (excluding methylaton levels features), we achieved an accu-
racy of 91.9% and an AUC of 0.96 (Figure 3.6A). We considered the role of each
subset of features (Table 3.1). For example, if we only include genomic position
features, the classifier had an accuracy of 78.6% and AUC of 0.85. Including DNA
sequence properties and TFBS features increased the accuracy to 85.7% and the AUC
to 0.92. When we included all classes of features except for neighbors, the classifier
achieved an accuracy of 89.0% and an AUC of 0.94, a significant improvement in pre-
diction from only considering genomic position features. (t-test; p “ 7.75 ˆ 10´23).
These results suggest that TFBSs, histone modifications, and chromatin state are
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predictive of DNA methylation. However, we also found that the genomic context
features improved prediction significantly over using only neighbors features, which
has an accuracy of 90.7% and an AUC of 0.94 (t-test; p “ 3.45ˆ 10´18).
Table 3.1: Performance of methylation status prediction using different prediction
models.
AUC: area under ROC curve; distance: the genomic distance between neighboring CpG sites; gene pos:
genomic position features including gene region status (promoter, gene body, and intergenic region),
CGI status (CGI, CGI shore, CGI shelf, and non-CGI), and proximal SNPs; seq property: DNA
sequence properties include GC content, recombination rate, conservation score, integrated haplotype
scores; CREs include TFBSs, DHS sites, histone modifications and chromatin state segmentations.
Feature set Features Accuracy (%) AUC Specificity (%) Sensitivity (%)
Gene pos 9 78.6 0.85 72.5 83.6
Gene pos + seq property 13 79.5 0.86 71.6 85.9
Gene pos + seq property + TFBSs 93 85.7 0.92 78.4 91.7
Gene pos + seq property + CREs 118 89 0.94 83.9 93.3
Neighbor + distance 4 90.7 0.94 87.2 93.5
All features 122 91.9 0.96 87.9 95.1
Cross-sample prediction
To determine how predictive methylation profiles were across samples, we quantified
the generalization error of our classifier genome-wide across individuals. In partic-
ular, we trained our classifier on 10,000 sites from one individual, and predicted
methylation status for all CpG sites for the other 99 individuals. The classifier
performance was highly consistent across individuals (Figure 3.7).
To test the sensitivity of our classifier to the number of CpG sites in the training
set, we investigated the prediction performance for different training set sizes. We
found that training sets with greater than 1, 000 CpG sites had fairly similar perfor-
mance (Figure 3.8). Throughout these experiments, we used a training set size of
10, 000, in order to strike a balance between sufficient numbers of training samples
and computational tractability.
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Figure 3.6: Prediction performance of methylation status and level prediction.
Panel A, B: ROC curves of within-genome validation of methylation status predic-
tion and prediction with different classifiers. Panel C: Precision-Recall curves of
region specific methylation status prediction. Panel D: 2D histogram of predicted
methylation levels versus experimental methylation levels distribution.
Cross-platform prediction
To quantify classification across platform and cell type heterogeinity, we investigated
the classifier performance on whole genome bisulfite sequencing (WGBS) data (Ziller
et al., 2013; Hodges et al., 2011). In particular, we categorized each CpG site in a
WGBS sample based on whether that CpG site was assayed on the 450K array (450K
site) or not (non 450K site); neighboring sites in the WGBS data are sites that are
adjacent on the genome and both 450K sites. We use one WGBS sample from b-
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Figure 3.7: ROC curves for methylation status prediction.
Each line represents the ROC curve for prediction of CpG sites, training and testing
the classifier on data from one individual.
cells, which will match some proportion of each whole blood sample; we note that
the 450K array whole blood samples will contain heterogeneous cell types in contrast
to the WGBS data. Overall, we see a much higher proportion of hypomethylated
CpG sites on the 450K array relative to the WGBS data (Figure 3.9) because of the
disproportionate representation of hypermethylated CpG sites within CGIs on the
450K array.
First, we investigated cross-platform prediction, training our classifier on a 450K
array sample and testing on WGBS data. We trained the classifier on 10, 000 CpG
sites in the 450K array samples, and then we tested on 100, 000 CpG sites twice –
once restricting the test set to 450K sites and once restricting the test set to non
450K sites – in WGBS data. We repeated this experiment ten times. Next, we
performed the same experiment but trained and tested on the WGBS data. Because
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Figure 3.8: Generalization error of prediction training size.
Colors represent different training set sizes. For each training set size, the ROC curve
is averaged over ten test sets across individuals.
the proportion of hypomethylated and hypermethylated sites was imbalanced for
CpG sites not on the 450K array, we used a precision-recall curve instead of a ROC
curve to measure the prediction performance (He and Garcia, 2009). We reversed
the methylation status in order to assess the quality of the predictions for the less
frequent class of hypomethylated CpG sites.
Trained on 450K array data and tested on WGBS 450K sites, our RF classifier
achieved an accuracy of 89.3%; trained on 450K array data and tested on WGBS
non 450K sites, our RF classifier achieved an accuracy of 92.2% (Figure 3.6; Table
3.2). Training and testing exclusively on WGBS data showed a similar performance,
with an accuracy of 90.0% for CpG sites in the 450K sites and 92.4% for CpG
sites in the non 450K sites (Figure 3.10). Predictions for CpG sites in non 450K
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Figure 3.9: Distribution of DNA methylation levels at CpG sites from whole-
genome bisulfite sequencing data.
Panel A: Distribution of DNA methylation levels across CpG sites from the WGBS
data that were categorized as 450K sites. Panel B: Distribution of DNA methylation
levels across CpG sites from the WGBS data that were categorized as non 450K
sites.
sites had lower precision at high recall rates because it is more difficult to predict
unmethylated sites in the sequencing data as there are many more unmethylated
CpG sites. These results suggest that our RF classifier is able to generalize across
platforms and methylation assay types.
Table 3.2: Performance of methylation prediction using Whole-Genome Bisulfite
Sequencing data.
Train set Test set Accuracy (%) Precision (%) Recall (%) R RMSE
WGBS 450K sites WGBS non 450K sites 92.4 86.5 44.5 0.64 0.24
WGBS 450K sites WGBS 450K sites 90 91.8 82.3 0.86 0.23
450K data WGBS non 450K sites 92.2 88.5 41.4 0.62 0.23
450K data WGBS 450K sites 89.3 93.0 79.3 0.84 0.24
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Figure 3.10: Prediction performance of Whole Genome Bisulfite Sequencing data.
Presicion-Recall curves were plotted for cross-platform prediction and WGBS pre-
diction. For each category, the curve was generated by averaging the results of all
held out test sets.
3.2.2 Comparison of random forest classifier with other classifiers
We compared the prediction performance of our RF classifier with several other
classifiers that have been widely used in related work (Table 3.3). In particular, we
compared our prediction results from a random forest (RF) classifier with those from
a support vector machine (SVM) classifier with a radial basis function (RBF) kernel,
a k-nearest neighbors classifier (k-NN), logistic regression (LR), and a naive Bayes
classifier (NB). We quantified performance using repeated random resampling, with
identical training and test sets across classifiers; we used identical feature sets for all
classifiers, including all 122 features used for prediction of methylation status with
the RF classifier
We found that k-NN showed the worst performance on this task, with an accuracy
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Table 3.3: Performance of methylation status prediction using different classifiers.
Classifier Accuracy (%) AUC Specificity (%) Sensitivity (%)
k-NN 73.2 0.80 72.6 73.7
Naive Bayes 80.8 0.91 64.4 94.2
Logistic Regression 91.1 0.96 87.3 94.1
SVM 91.3 0.96 86.6 95.1
Random Forest 91.8 0.96 87.9 95.1
of 73.2% and an AUC of 0.80 (Figure 3.6B). The NB classifier showed better accuracy
(80.8%) and AUC (0.91). Logistic regression and the SVM classifier both showed
good performance, with accuracies of 91.1% and 91.3% and AUCs of 0.96% and
0.96%, respectively. We found that our random forest classifier showed significantly
better prediction accuracy than logistic regression (t-test; p “ 3.8 ˆ 10´16) and the
SVM (t-test; p “ 1.3 ˆ 10´13). We note also that the computational time required
to train and test the RF classifier was substantially less than the time required for
the SVM, k-NN (test only), and NB classifiers. We chose RF classifiers for this task
because, in addition to the gains in accuracy over SVMs, we were able to quantify
the contribution to prediction of each feature, which we describe below.
3.2.3 Region specific methylation status prediction
Studies of DNA methylation have focused on methylation within promoter regions,
restricting predictions to CGIs (Bock et al., 2006; Fang et al., 2006; Fan et al.,
2008; Previti et al., 2009; Lu, 2010; Zhou et al., 2012; Zheng et al., 2013); we and
others have shown DNA methylation has different patterns in these genomic regions
relative to the rest of the genome (Jones, 2012), so the accuracy of these prediction
methods outside of these regions is unclear. Here we investigated regional DNA
methylation prediction for our genome-wide CpG site prediction method, restricted
to CpGs within specific genomic regions (Table 3.4). For this experiment, prediction
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was restricted to CpG sites with neighboring sites within 1 kb distance because of
the limited size of CGIs.
Within CGI regions, we found that predictions of methylation status using our
method had an accuracy of 98.3%. We found that methylation level prediction
within CGIs had an r “ 0.94 and a RMSE of 0.09. As in related work on prediction
within CGI regions, we believe the improvement in accuracy is due to the limited
variability in methylation patterns in these regions; indeed, 90.3% of CpG sites in
CGI regions have a β ă 0.5 (Table 3.4). Conversely, prediction of CpG methylation
status within CGI shores had an accuracy of 89.8%. This lower accuracy is con-
sistent with observations of robust and drastic change in methylation status across
these regions (Irzarry, 2009; Doi et al., 2009). Prediction performance within vari-
ous gene regions was fairly consistent, with 94.9% accuracy for predictions of CpG
sites within promoter regions, 93.4% accuracy within gene body regions (exons and
introns), and 93.1% accuracy within intergenic regions. Because of the imbalance
of hypomethylated and hypermethylated sites in each region, we evaluated both the
precision-recall curves and ROC curves for these predictions (Figure 3.5C and Figure
3.11).
Table 3.4: Region specific methylation prediction.
Num sites: Number of CpG sites; Num sites 1k: Number of sites with both neigh-
bors within 1 kb; Methy%: Percentage of n corresponding regions with neigh-
boring CpG site within 1 kb distance; Num CV: Number of random subsamples.
Region Num sites Num sites 1k Methy% CV Accuracy (%) AUC Precision (%) Recall (%)
Promoter 157,468 108,063 0.2070 10 94.98 0.9836 89.06 86.41
Gene body 117,424 35,072 0.6369 3 93.45 0.9741 94.13 95.60
Intergenic 91,177 25,694 0.3960 2 93.05 0.9738 91.23 90.59
CGI 110,612 66,533 0.0973 6 98.32 0.9931 93.94 88.50
CGI shore 89,989 28,232 0.4210 2 89.83 0.9584 88.46 87.15
CGI shelf 36,658 4,736 0.7445 4 89.79 0.9514 89.88 97.54
non-CGI 141,418 34,657 0.7149 3 91.93 0.9489 92.32 96.69
All 378,677 189,735 0.3228 10 91.85 0.9624 90.61 95.06
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Figure 3.11: Prediction performance of region specific methylation status.
ROC curves of region specific methylation status prediction. Colors represent pre-
dictions of CpG site methylation status within different genomic regions. For each
category, the curve was generated by averaging the results across held out test sets.
3.2.4 Predicting genome-wide methylation levels across platform
CpG methylation levels β in a DNA sample represent the average methylation status
across the cells in that sample and will vary continuously between 0 and 1. Since the
Illumina 450K array enables precise methylation levels at CpG site resolution in each
sample, we used our RF classifier to predict methylation levels at single CpG site
resolution. We used the prediction probability as the predicted methylation level.
Using all 122 features (excluding methylation status features), we trained our RF
classifier on 450K array data and evaluated the Pearson’s correlation coefficient (r)
and root-mean squared error (RMSE) between experimental and predicted methyla-
tion levels (Table 3.5; Figure 3.6D). We found that the experimentally assayed and
predicted methylation levels had an r “ 0.90 and RMSE “ 0.19. The correlation co-
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efficient and the RMSE indicate good recapitulation of experimentally assayed levels
using predicted methylation levels across CpG sites.
Table 3.5: Performance of methylation levels prediction using different prediction
models.
Feature set Features R RMSE
Gene pos 9 0.61 0.39
Gene pos + seq property 13 0.66 0.34
Gene pos + seq property + TFBSs 93 0.80 0.29
Gene pos + seq property + CREs 118 0.86 0.23
Neighbor + distance 4 0.87 0.24
All features 122 0.90 0.19
We quantified the performance of methylation level prediction on WGBS data.
Trained on CpG sites from the 450K array, and tested the classifier on CpG sites from
the WGBS data, both restricted to CpG sites in the 450K sites set and restricted to
CpG sites in the non 450K sites set. We achieved different correlation (r “ 0.62, 0.84,
p ă 2.2ˆ10´16) while much closer RMSE (RMSE “ 0.23, 0.24, p “ 3ˆ10´16) when
predicting methylation levels for CpG sites in the 450K site set and CpG sites in the
non 450K site set, respectively, in WGBS data (Table 3.6).
Table 3.6: Region specific methylation levels prediction.
Region Num sites Num sites 1k Methy% CV R RMSE
Promoter 157,468 108,063 0.2070 10 0.9231 0.1346
Gene body 117,424 35,072 0.6369 3 0.9247 0.1681
Intergenic 91,177 25,694 0.3960 2 0.9176 0.1689
CGI 110,612 66,533 0.0973 6 0.9433 0.0926
CGI shore 89,989 28,232 0.4210 2 0.8892 0.1814
CGI shelf 36,658 4,736 0.7445 4 0.8779 0.1871
non-CGI 141,418 34,657 0.7149 3 0.8914 0.1910
All 378,677 189,735 0.3228 10 0.9016 0.1919
3.2.5 Feature importance for methylation prediction
We evaluated the contribution of each feature to overall prediction accuracy, as
quantified by the Gini index. The Gini index measures the decrease in node impurity,
or the relative entropy of the observed positive and negative examples before and
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after splitting the training samples on a single feature, of a given feature over all
trees in the trained RF. We computed the Gini index for each of the 122 features
from the trained RF classifier for predicting methylation status. We found that
upstream and downstream neighboring CpG site methylation status are the most
important features for prediction (Appendix C, Figure 3.12). We found that the
feature rankings based on Gini index differed when predicting methylation status
in specific genomic regions (Figure 3.7), implying context-specific DNA methylation
mechanisms. When we restrict prediction to promoter or CGI regions, the Gini score
of the neighboring site status features increased relative to other features, which
is consistent with previous results showing high DNA methylation correlation and
prediction performance in CGI and promoter resiongs. In contrast, we found that the
Gini index of the genomic distance to the neighboring CpG site feature decreased,
suggesting that neighboring genomic distance is an important feature to consider for
cross-region prediction or prediction cross long genomic distance.
We found that DHS sites are strongly predictive of an unmethylated CpG site;
the DHS site feature has the third most significant Gini index across these experi-
ments. This observation is consistent with a previous study showing that CpG sites
in DHS sites tend to be unmethylated Tsumagari et al. (2013). CGI status is also
an important feature, which is unsurprising given that most CpG sites in CGIs are
unmethylated. GC content, which also ranked highly based on Gini index, may have
a substantial contribution to prediction as a proxy for other important features, such
as CGI status and CpG density. GC content, which was also ranked highly based on
Gini index, may have a substantial contribution to prediction as a proxy for other
important features, such as CGI status and CpG density.
Several TFs and histone modifications were among the most highly ranked fea-
tures across experiments, while the specific ranking varies. Some of these CREs
have been suggested to be associated with DNA methylation, including Elf1, Runx3,
34
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Figure 3.12: Top 20 most important features by Gini score.
Gini scores for the top 20 features in predictions in different genomic regions. Panel
A: Prediction in any genomic region. Panel B: Prediction in promoter regions. Panel
C: Prediction in CGIs. The different colors represent different type of features:
Neighbors in red, Gene Pos in green, seq property in blue and others in black.
MAZ, Mxi1, and Max. Indeed, the ETS-related transcription factor (Elf1) has been
shown to be overrepresented in methylated regions, associating DNA methylation
with hematopoiesis in hematopoietic stem cells (Hogart et al., 2012). Runx3 (Runt-
related transcription factor 3), a strong tumor suppressor associated with diverse
tumor types, has been suggested to be associated with cancer development through
regulating global DNA methylation levels (Chuang and Ito, 2010; Li et al., 2002;
Kim et al., 2005; Lau et al., 2006; Sato et al., 2006; Weisenberger et al., 2006).
Runx3 expression is associated with aberrant DNA methylation in adenocarcinoma
cells (Sato et al., 2006), primary bladder tumor cells (Kim et al., 2005), and breast
cancer cells (Lau et al., 2006). For another tumor suppressor transcription factor,
Mxi1 (MAX-interacting protein 1), expression levels (specifically, lack of expression)
have been reported to be associated with promoter methylation levels and neurob-
lastic tumorigenesis (La´zcoz et al., 2007). It has been suggested that suppression of
35
MAZ (Myc-associated zinc finger protein) may be associated with DNA methyltrans-
ferase I, the key factor for de novo DNA methylation (Song et al., 2001, 2003). Mxi1
and MAX (Myc-associated factor X) both interact with c-Myc (myelocytomatosis
oncogene), a well characterized oncogene, which has been shown to be methylation
sensitive, meaning that the TF motifs contain CpG sites and, thus, TF binding is
sensitive to methylation status at those sites (Baron, 2012). This suggests a poten-
tial regulatory relationship between MAX, Mxi1, and DNA methylation that may
extend to downstream cancer tumor development. The association between spe-
cific histone modifications and DNA methylation is poorly understood. A previous
study suggested that high H3K4 methylation and Hs acetylation are associated with
Myc recognition (Guccione et al., 2006), suggesting regulatory relationships among
DNA methylation, histone modification, and transcription factor binding. Our re-
sults suggest that further work is needed to investigate the association between DNA
methylation and specific histone modification marks.
We found that the correlation between a binary feature and PC1 is proportional
to the Gini index of that feature (Figure 3.4 and Appendix D). The variation in
the Gini index rankings for CREs varied more than we expected based on the other
features (Figure 3.13). CREs that co-occur with CpG sites more often tend to be
more important for prediction, according to the Gini index. We found that the
Gini index of a binary feature has a log linear relationship with the number of co-
occurrences of that binary feature with CpG sites in the data set: the more often a
CpG site in the training data co-occurred with a CRE, the higher the Gini index rank
of that CpG site (Figure 3.13). There were several outliers to this trend, including
status of promoter Pol3 (RNA polymerase III), C-fos (a proto-oncogene), and histone
modifications H3K9ac and H4K20me. These features were less important than we
would predict using the fitted linear regression model of log Gini index. This trend
limits the strong conclusions that associate specific CREs with DNA methylation
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biochemically from a high Gini index rank for that CRE; it may be that there
are general relationships between CRE and CpG sites that we are learning, but
a relatively high CRE frequency in these data will artificially inflate the rank of that
CRE in comparison to the others (Figure 3.13). Most CpG sites within TFBSs have
low average methylation levels (Appendix D). Several TFBSs have disproportionately
high average methylation levels: for example ZNF274 (Zinc-finger protein 274) and
JunD (Jun D proto-oncogene); however, both of these outliers also have a low co-
occurrence frequency with CpG sites in these data, suggesting that this finding may
be an artifact.
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Figure 3.13: Correlation of Gini index and the co-occurrence counts of binary
features.
The x-axis represents the number of CpG sites co-localized with the corresponding
feature (the number of CpG sites that were encoded as ‘1’ for corresponding feature).
The y-axis represents the log value of Gini scores of prediction with neighboring CpG
site of arbitrary distance. The line was fitted by linear regression. The outliers are
highlighted in red. UpMethy: upstream CpG site’s methylation status; DownMethy:
downstream CpG site’s methylation status; Pol3, Cfos, Rxra: TFBSs of Pol3, c-fos
and Rxr-α.
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4Discussion
Genome-wide association studies (GWAS) have successfully identified many gene lo-
cus associated with common diseases. However, a large percentage of causality still
cannot be explained by genetic variation but has been shown to associate with epi-
genetic factors. As one of the most important epigenetic modification, DNA methy-
lation has been shown to have downstream effects on cell differentiation, embryonic
development, aging, and cancer. Although genome-wide DNA methylation profiling
technologies are available, most of the genome-wide DNA methylation studies are
using a variety of different technologies with limited and varied genomic coverages,
which 1) do not characterize the whole genome methylome, 2) introduce difficulties
in comparison of different studies and 3) create significant barriers of meta-analysis.
Thus, computational prediction of DNA methylation is of great interest for cost and
time saving, missing data filling and meta-analysis that facilitate information sharing
and collaboration in scientific community.
In this work, we first characterized genome-wide context-dependent DNA methy-
lation pattern. We found that the correlation of DNA methylation decreases rapidly
within short genomic distance, making it difficult to predict DNA methylation lev-
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els solely using neighboring DNA methylation information. On the other hand, we
found that DNA methylation patterns and correlations are highly genomic context-
dependent. It has recently been found that CGI shore regions have distinct methy-
lation pattern from CGIs and the high variation in CGI shore regions may relate to
tumorigenesis (Irzarry, 2009; Doi et al., 2009). We indeed observed distinct methy-
lation patterns in CGI, CGI shore and CGI shelf regions. In a further step, we
found that not only the DNA methylation levels are distinct, but also the correla-
tion between neighboring CpG sites are distinct. The correlation in CGI regions is
constantly higher than other regions; the correlation in CGI shore and shelf regions
decreases rapidly in relation to genomic distance. Besides, the correlation in CGI
shore and shelf regions are also correlated with the relative location of the CpG sites
within the CGI shore and shelf, implying that the correlation structure could be
useful in modeling DNA methylation and predicting DNA methylation levels.
Based on the DNA methylation patterns and previous findings, we built pre-
diction classifiers to predict DNA methylation levels in humans. We incorporated
multiple information as prediction features, including 1) neighboring CpG site methy-
lation levels and genomic distance, 2) genomic position such as CGI regions and
gene coding regions, 3) DNA sequence property such as recombination rate and GC
content, and 4) regulatory elements such as transcription factor binding sites and
histone modification marks. By using 122 genomic features, we could predict both
DNA methylation status and levels with high accuracy cross genome and samples
using both genome-wide microarray and bisulfite sequencing data. Our high predic-
tion performance of cross platform prediction implied that our classifiers is highly
applicable to enable meta-analysis that consolidate results from different methyla-
tion techniques and platforms. It could be applied to expand previous studies using
techniques with low measurement density.
Except our high accuracy, our classifiers allow us to quantify the contribution
39
of each feature to DNA methylation prediction. Except neighboring site methyla-
tion levels, we identified several features that are highly predictive, including co-
localization of DNase I Hypersensitive sites, GC content, and several TFBSs and
histone modification marks such as Elf1, H3K27ac, H3K4me3, Mxi1 and Max. Our
classifier could not only predict DNA methylation but also suggest genomic features
that may regulate, or be regulated by, DNA methylation. These results imply im-
portant regulatory mechanisms of DNA methylation in human cells.
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Appendix A
Appendix A
The table shows related work on DNA methylation prediction. MethDB is a database
of measurements of DNA methylation from variety of studies and methods (Amoreira
et al., 2003), which is regularly updated. HEP: Human Genome Project, which
contains about 1.9 million CpG methylation values from chromosomes 6, 20 and 22
from 12 cell types across 43 samples.
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Appendix B
Appendix B
List of features prediction feature. Columns include the category of features, the
source of the data, and the name of the features.
Category Source Feature Name
Neighbors
Methylation 450K data Upstream neighboring CpG site
methylation status & level
Downstream neighboring CpG
site methylation status & level
Distance features Upstream neighboring distance
Downstream neighboring dis-
tance
Genomic Position
Methylation 450K annotation SNPs present within probe ą
10bp from query site
SNPs present within probe ă
10bp from query site
UCSC database knownGene.txt.gz Presence in promoter
Presence in gene body
Presence in intergenic region
UCSC database cpgIslandExt.txt.gz Presence in CpG island
Presence in CGI shore
Presence in CGI shelf
Presence in non-CGI region
DNA seq property
Genome Evolutionary Rate Profiling
(GERP)
Constraint Score
hgdp selection brower smoothedAmeri-
cas.iHS.gff
Integrated Haplotype Score
(iHS)
HapMap recombination/2011-
01 phaseII B37/
Recombination Rate
UCSC goldenPath hg19.gc5Base.txt.gz GC Content
44
Cis-regulatory
elements
ENCODE UCSC Accession wgEn-
codeEH000534
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ENCODE Track Name TFBS, narrow-
Peak, Cell type: GM12878, Date freeze
before July 2012
CTCF
Cfos
E2F4
EBF1
ELK1
GCN5
IKZF1
IRF3
Jund
MAZ
Max
Mxi1
NFE2
NFYA
NFYB
Nfkb
Nrf1
P300
Pol2
Pol2 S2
Pol3
RFX5
Rad21
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SMC3
SPT20
STAT1
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Yy1
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Atf2
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Gabp
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Mef2a
Mef2c
Mta3
Nfatc1
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Pax5
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Pol24h8
Pou2f2
Pu1
RFX5
Runx3
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Srf
Stat5a
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Tcf12
Tcf3
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c.Myc
ENCODE Track name histone modifi-
cation, Peak, Cell type: GM12878
H3K4me1
H3K04me3
H3K4me2
H3K9ac
H3K9me3
H3K27ac
H3K27me3
H3K36me3
H3K79me2
H4k20me1
UCSC Accession wgEn-
codeEH000033 wgEncodeBroadHm-
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Active promoter
Weak promoter
Inactive promoter
Strong enhancer
Strong enhancer2
Weak enhancer
Weak enhancer2
Insulator
Transcriptional transition
Transcriptional elongation
Weak transcribed
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Polycomb
Heterochromatin
Repetitive
CNV
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Appendix C
Gini importance scores for all features. Gini all: Gini scores for prediction in
any genomic regions; Gini promoter: Gini scores for prediction in promoter regions;
Gini CGI: Gini scores for prediction in CGIs.
Feature Name Gini all Gini promoter Gini CGI
Upstream neighbor CpG site methylation status 541.552 534.886 399.055
Downstream neighbor CpG site methylation status 531.864 535.967 402.254
DHS site 273.547 131.399 44.035
Upstream neighbor CpG site distance 241.021 77.379 22.678
Downstream neighbor CpG site distance 237.204 78.518 23.936
GC content 168.279 118.312 32.919
Elf1 162.508 77.157 19.12
H3K27ac 149.77 59.323 43.451
Within CGI 148.856 121.591 NA
MAZ 137.958 72.734 16.621
H3K4me3 110.184 50.229 36.9
Recombination rate 104.877 59.93 22.709
Mxi1 99.106 52.39 8.424
Runx3 94.866 37.644 7.971
Max 82.612 39.422 9.318
Heterochromatin 79.684 106.136 77.419
ZNF143 76.93 37.272 8.703
Polycomb 63.44 27.453 34.14
Active promoter 62.11 24.761 5.7
Pml 61.002 27.392 5.936
H3K9ac 55.64 33.347 50.589
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Presence of non-CGI 54.75 94.865 NA
H3K36me3 53.501 22.92 13.819
iHS 47.941 28.896 10.067
Mta3 47.802 18.679 4.93
CHD2 44.864 27.873 5.476
Constraint score 42.809 29.204 13.145
BHLHE40 35.904 20.189 4.537
H3K9me3 32.004 18.461 15.002
Presence of promoter 31.598 NA 36.049
Pol2 29.515 17.188 3.097
Weak transcribed 25.533 25.837 41.617
Presence of CGI shelf 25.461 6.503 NA
Presence of CGI shore 24.028 20.577 NA
H3K4me2 23.788 12.885 6.843
Presence of gene 21.74 NA 39.436
SIN3A 21.18 12.887 2.066
H4K20me1 21.122 13.009 5.988
CTCF 19.86 8.4 2.733
Stat5a 19.513 8.783 2.268
STAT1 18.935 10.579 1.749
H3K79me2 18.573 11.452 5.647
H3K27me3 18.487 12.541 4.745
H3K04me1 18.311 11.599 5.42
Presence in intergenic region 15.118 NA 4.743
TBLR1 14.654 7.967 1.551
COREST 14.605 8.455 1.497
WHIP 12.743 6.98 0.507
SMC3 12.541 4.34 1.252
SNPs present within probe ą 10bp from query site 11.814 6.986 2.629
Taf1 11.667 8.857 1.414
CHD1 11.445 6.645 1.178
Pol2 S2 10.963 10.742 2.869
SNPs present within probe ă 10bp from query site 10.129 5.429 2.292
EBF1 10.062 6.626 1.02
Weak enhancer 9.716 6.95 3.011
Weak promoter 9.302 6.965 2.074
Transcriptional elongation 8.955 3.349 14.994
Sp1 8.231 8.698 2.218
Weak enhancer2 8.018 6.15 1.685
Pu1 7.836 2.423 0.327
Pol24h8 7.65 6.756 1.829
Inactive promoter 7.448 6.177 1.147
Pou2f2 7.413 6.137 1.42
Strong enhancer 7.401 6.207 1.184
Foxm1 6.941 5.752 0.924
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Insulator 6.57 2.888 2.127
Rad21 6.496 1.607 0.399
TBP 5.239 5.528 0.605
Strong enhancer2 4.939 2.177 0.486
P300 4.913 3.742 0.424
ELK1 4.727 3.497 0.434
Zeb1 4.655 4.064 1.558
Pax5 4.565 2.944 1.251
Transcriptional transition 3.65 1.876 1.74
NFYB 3.617 3.331 0.643
IKZF1 3.583 1.85 0.07
Batf 3.542 1.382 0.091
USF2 3.48 2.833 0.502
Nfatc1 3.422 3.083 0.725
Nrf1 3.32 3.734 0.905
RFX5 2.818 2.333 0.321
Atf2 2.431 1.831 0.184
Bclaf1 2.333 2.099 0.366
Nfic 2.162 1.299 0.076
STAT3 2.023 1.503 0.053
Nfkb 1.94 1.316 0.036
Irf4 1.91 1.25 0.188
Tcf12 1.827 0.999 0.355
Bcl11a 1.813 0.951 0.224
Pbx3 1.631 0.801 0.123
Bcl3 1.458 0.569 0.651
Mef2a 1.365 0.725 0.059
Tcf3 1.328 0.679 0.409
Repetitive 1.23 0.743 0.426
BRCA1 1.218 0.829 0.213
Nrsf 1.147 0.783 0.288
Mef2c 1.109 0.663 0.027
Usf1 1.047 0.775 0.314
c.Myc 0.764 0.697 0.299
Zbtb33 0.631 0.402 0.095
IRF3 0.583 0.592 0.024
Six5 0.564 0.778 0.029
E2F4 0.546 0.595 0.098
Gabp 0.529 0.616 0.208
NFE2 0.515 0.426 0.042
NFYA 0.512 0.404 0.045
Ets1 0.418 0.635 0.116
Atf3 0.418 0.525 0.034
Tr4 0.404 0.431 0.005
GCN5 0.334 0.314 0.045
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Yy1 0.31 0.432 0.026
SPT20 0.307 0.326 0.044
Srf 0.282 0.181 0.103
CNV 0.256 0.106 0.21
Egr1 0.232 0.35 0.122
Jund 0.178 0.177 0
Zzz3 0.145 0.246 0.017
ZNF274 0.13 0.024 0
Rxra 0.088 0.012 0.027
Cfos 0.057 0.091 0.011
Pol3 0.006 0.002 0
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Number of occurrences and methylation levels of binary features. Columns are Fea-
ture name, Feature counts (or the number of CpG sites that co-occur with these
features in our data), and percentage of methylation CpG sites (or the proportion of
CpG sites that co-occur with these features that are methylated).
Feature Name Feature counts Percentage of methylated CpG sites
Upstream neighboring CpG site methylation status 208536 0.841
Downstream neighboring CpG site methylation status 208535 0.841
SNPs present within probe ą 10bp from query site 45374 0.578
SNPs present within probe ă 10bp from query site 26557 0.64
DHS site 121516 0.111
Presence in CGI 110612 0.161
Presence in CGI Shore 89989 0.468
Presence in CGI Shelf 36658 0.864
Presence in non-CGI 141418 0.819
Presence in Promoter 157468 0.314
Presence in Gene body 117424 0.729
Presence in Intergenic region 91177 0.673
Atf2 28854 0.067
Atf3 7280 0.017
BHLHE40 70342 0.05
BRCA1 18594 0.023
Batf 14022 0.162
Bcl11a 7539 0.163
Bcl3 2759 0.356
Bclaf1 33688 0.05
CHD1 54108 0.041
CHD2 72260 0.042
COREST 58915 0.042
CTCF 48396 0.071
Cfos 5154 0.004
E2F4 17883 0.011
EBF1 56467 0.089
ELK1 44385 0.021
Egr1 5257 0.016
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Elf1 89501 0.048
Ets1 14155 0.01
Foxm1 52346 0.043
GCN5 4176 0.023
Gabp 15904 0.007
IKZF1 8503 0.208
IRF3 11087 0.023
Irf4 14074 0.098
Jund 155 0.468
MAZ 83459 0.035
Max 77542 0.037
Mef2a 5499 0.12
Mef2c 4813 0.125
Mta3 88190 0.101
Mxi1 80851 0.042
NFE2 6491 0.039
NFYA 10329 0.018
NFYB 28315 0.042
Nfatc1 38120 0.089
Nfic 20773 0.084
Nfkb 4235 0.183
Nrf1 42227 0.018
Nrsf 4514 0.023
P300 39077 0.043
Pax5 42760 0.051
Pbx3 12800 0.044
Pml 81813 0.07
Pol2 77520 0.086
Pol24h8 68843 0.124
Pol2 S2 77669 0.14
Pol3 255 0.006
Pou2f2 55632 0.055
Pu1 17400 0.082
RFX5 36423 0.025
Rad21 11054 0.1
Runx3 85861 0.067
Rxra 1410 0.029
SIN3A 55349 0.014
SMC3 36131 0.08
SPT20 1867 0.112
STAT1 58324 0.03
STAT3 15220 0.083
Six5 7402 0.025
Sp1 51817 0.03
Srf 2987 0.043
Stat5a 65821 0.067
TBLR1 59257 0.045
TBP 50953 0.041
Taf1 52199 0.015
Tcf12 11512 0.083
Tcf3 17033 0.051
Tr4 2589 0.061
USF2 34220 0.048
Usf1 7466 0.034
WHIP 57505 0.092
Yy1 1827 0.044
ZNF143 75729 0.043
ZNF274 194 0.696
Zbtb33 5558 0.048
Zeb1 37222 0.033
Zzz3 838 0.049
c.Myc 11989 0.019
H3K4me1 132850 0.369
H3K4me3 155476 0.235
H3K4me2 111551 0.210
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H3K9ac 166816 0.52
H3K9me3 133511 0.51
H3K27ac 155274 0.225
H3K27me3 118352 0.325
H3K36me3 122475 0.191
H3K79me2 73603 0.507
H4K20me1 188613 0.524
Active promoter 70341 0.041
Weak promoter 25332 0.236
Inactive promoter 11843 0.43
Strong enhancer 11843 0.43
Strong enhancer2 3720 0.714
Weak enhancer 13960 0.375
Weak enhancer2 8930 0.784
Insulator 6438 0.367
Transcriptional transition 4255 0.876
Transcriptional elongation 18777 0.956
Weak transcribed 35266 0.918
Polycomb 41145 0.36
Heterochromatin 121981 0.881
Repetitive 614 0.480
CNV 210 0.567
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